These T cells effectively lysed a variety of CD20+ tumor cells at low E:T ratios and secreted abundant IFNγ, TNF-α, and IL-2 upon tumor recognition, highlighting their CD20 specificity and potent effector function. The gene discussed is IFNG; the disease is neoplasm.